Speaker: Kevin Spelman. The last few decades have provided increasing evidence that botanically based immunomodulators are efficacious for a variety of conditions. However, the molecular modes of activity are rarely mentioned. In this lecture the clinical use and molecular underpinnings, including the activities of nitric oxide, adhesion molecules and cytokines, are discussed and clinically applied. Current research is described and evaluated.